Table 3: Association of anti-HCV seroprevalence with signs and symptoms of participants.

HCV-ELISA
Variables Positive (%) Negative (%) Total (%) χ2 p-value
Fever
Present
Absent
42(15.6)
8 (3.0)
177(65.6)
43(15.9)
212 (81.1)
51(18.9)
0.334 0.362
Jaundice
Present
Absent
0 (0.0)
50 (18.5)
19 (7.0)
201 (74. 4)
19 (7.0)
251 (93.0)
4.645 0.018
Joint pain
Present
Absent
8 (3.0)
42 (15.6)
21 (7.8)
199 (73.7)
29 (10.7)
241 (89.3)
0.770 0.141
Itchy Skin
Present
Absent
2 (0.7)
48 (17.8)
11 (4.1)
209 (77.4)
13 (4.8)
257 (95.2)
1.807 0.177
Loss of appetite
Present
Absent
22 (8.1)
28 (10.4)
114 (42.2)
106 (39.3)
136 (50.4)
134 (49.6)
0.996 0.200
Weakness/fatigue
Present
Absent
19 (7.0)
31 (11.5)
102 (37.8)
117(43.3)
121 (44.8)
148 (54.8)
1.441 0.486
Abdominal Pains
Present
Absent
14 (5.2)
36 (13.3)
53 (19.6)
167 (61.9)
67 (24.8)
203 (75.2)
0.334 0.340
Dark Urine
Present
Absent
9 (3.4)
41 (15.2)
10 (3.7)
210 (77.8)
19 (7.0)
251 (93.0)
13.212 0.01